Milestone Pharmaceuticals Inc share price logo

Milestone Pharmaceuticals Inc Share Price

NASDAQ: MIST

Small Cap

$1.97

+0.06

(+2.88%)

as on

Milestone Pharmaceuticals Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.87
    $1.99
    downward going graph

    5.08%

    Downside

    1.02%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.63
    $2.75
    downward going graph

    68.25%

    Downside

    39.59%

    Upside

    downward going graph

Milestone Pharmaceuticals Inc share price movements today

Previous Close
$1.91
Open
$1.89
Volume
2.6M
Day's Low - High
$1.87 - $1.99
52 Week Low - High
$0.63 - $2.75

Milestone Pharmaceuticals Inc Historical Returns

1 Month Return
+ 15.29 %
3 Month Return
+ 18.79 %
1 Year Return
+ 28.95 %
3 Year Return
-78.58 %
5 Year Return
-75.92 %

Milestone Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Milestone Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$166.6M

EPS (TTM)

-0.89

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.27

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-54.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

456589700.00%

Milestone Pharmaceuticals Inc Stock Valuation

Track how Milestone Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Milestone Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (-1.27x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.27x

Milestone Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Milestone Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$166.6M-75.92%-1.270.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Milestone Pharmaceuticals Inc Stock including INR - Dollar returns

The Milestone Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Milestone Pharmaceuticals Inc investment value today

Current value as on today

₹1,34,744

Returns

₹34,744

(+34.74%)

Returns from Milestone Pharmaceuticals Inc Stock

₹29,605 (+29.61%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Milestone Pharmaceuticals Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Milestone Pharmaceuticals Inc. Average target price of $3.5

Milestone Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Milestone Pharmaceuticals Inc.

What analysts predicted

43.71%UPSIDE

Target Price

$3.5

Current Price

$1.97

Analyzed by

10 Analysts

Target

$3.50

Milestone Pharmaceuticals Inc target price $3.5, a slight upside of 43.71% compared to current price of $1.97. According to 10 analysts rating.

Milestone Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Milestone Pharmaceuticals Inc Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-42% versus previous 30 day period

Milestone Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
-
-
0
0
-
-
0
-
-
Gross Profit
1
0
0
-1
0
0
0
0
0
0
Operating Income
-15
-16
-15
-13
-10
-9
-9
-12
-20
-12
EBITDA
-14
-15
-14
-13
-9
-8
-8
-12
-19
-11
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-16
-15
-13
-10
-9
-9
-12
-20
-12
Income Tax Expense
0
1
1
0
0
0
-
0
0
-
Net Income
-14
-16
-15
-13
-10
-9
-9
-12
-20
-12
Net Profit Margin
-1495.00%
0.00%
0.00%
1568.08%
1192.85%
0.00%
0.00%
-11447.22%
0.00%
0.00%

Milestone Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
15
15
5
1
-
Gross Profit
0
0
0
0
15
5
1
0
Operating Income
-8
-23
-57
-50
-43
-59
-61
-42
EBITDA
-8
-23
-57
-50
-42
-59
-56
-42
Interest Expense
-
-
2
0
0
1
2
-3
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-8
-23
-55
-49
-42
-58
-59
-41
Income Tax Expense
0
0
0
0
0
-1
0
0
Net Income
-8
-23
-55
-49
-42
-57
-59
-41
Net Profit Margin
0.00%
0.00%
0.00%
-333.11%
-284.22%
-1142.68%
-5968.50%
0.00%

Milestone Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-16
-15
-13
-10
-9
-9
-12
-20
-12
Operating Cash Flow
-10
-12
-9
-8
-6
-7
-6
-13
-12
Investing Cash Flow
-28
-10
-
-27
9
6
19
33
9
Financing Cash Flow
-2
0
0
32
0
0
0
0
0
Change in Cash
-41
-22
3
-3
3
0
12
19
-2

Milestone Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-23
-55
-49
-42
-58
-59
-41
Operating Cash Flow
-21
-51
-50
-33
-52
-46
-28
Investing Cash Flow
15
0
-70
70
-57
4
8
Financing Cash Flow
80
85
73
5
3
47
32
Change in Cash
75
33
-47
41
-106
6
11

Global Institutional Holdings in Milestone Pharmaceuticals Inc

Funds
Holdings
RTW INVESTMENTS, LLC
2.95%
Propel Bio Management LLC
1.71%
Alta Fundamental Advisers LLC
1.68%
BML Capital Management LLC
1.34%
Morgan Stanley - Brokerage Accounts
1.14%

Insights on Milestone Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MIST stock has moved up by 12.0%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -20.76M → -12.96M (in $), with an average increase of 60.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -868.00K → 108.0K (in $), with an average increase of 903.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 202.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 46.7%

About Milestone Pharmaceuticals Inc

milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.
OrganisationMilestone Pharmaceuticals Inc
Headquarters1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
IndustryPharmaceuticals: Major
CEOMr. Joseph G. Oliveto M.B.A.
E-voting on sharesClick here to vote

Key Management of Milestone Pharmaceuticals Inc

Name

Title

Mr. Roshan Girglani

Vice President of Marketing

Mr. Jeff Moore

Vice President of Sales

Mr. Lorenz Muller

Chief Commercial Officer

Mr. Joseph G. Oliveto M.B.A.

CEO, President & Director

Mr. Amit Hasija

CFO & Executive VP of Corporate Development

Dr. David B. Bharucha FACC, M.D., Ph.D.

Chief Medical Officer

Dr. Guy Rousseau

SVP of Regulatory Affairs and Quality Management

Dr. Philippe Douville M.B.A., Ph.D.

Founder, Strategic Advisor & Member of Scientific Advisory Board

Mr. Jeffrey Nelson

Chief Operating Officer

Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.

Chief Medical Advisor & Member of the Scientific Advisory Board

FAQs

What is Milestone Pharmaceuticals Inc share price today?

Milestone Pharmaceuticals Inc share price today is $1.97 as on at the close of the market. Milestone Pharmaceuticals Inc share today touched a day high of $1.99 and a low of $1.87.

What is the 52 week high and 52 week low for Milestone Pharmaceuticals Inc share?

Milestone Pharmaceuticals Inc share touched a 52 week high of $2.75 on and a 52 week low of $0.63 on . Milestone Pharmaceuticals Inc stock price today i.e. is closed at $1.97,which is 28.36% down from its 52 week high and 215.00% up from its 52 week low.

What is Milestone Pharmaceuticals Inc's market capitalisation today?

Milestone Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Milestone Pharmaceuticals Inc Stock (MIST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Milestone Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Milestone Pharmaceuticals Inc Shares that will get you 0.7614 shares as per Milestone Pharmaceuticals Inc share price of $1.97 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Milestone Pharmaceuticals Inc Stock (MIST) from India?

Indian investors can start investing in Milestone Pharmaceuticals Inc (MIST) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Milestone Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Milestone Pharmaceuticals Inc share’s latest price of $1.97 as on September 13, 2025 at 1:29 am IST, you will get 5.0761 shares of Milestone Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Milestone Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Milestone Pharmaceuticals Inc stock has given -75.92% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?